|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$37,794
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-07
|
$9,000
|
$900
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
West Coast AIDS and Cancer Specimen Resource (ACSR)
|
2U01CA066529-14
|
$1,173,954
|
$293,489
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-32
|
$306,523
|
$76,631
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Viral Oncology Training Grant
|
2T32CA009111-31A2
|
$318,261
|
$31,826
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral and cellular gene regulation during lytic KSHV replication
|
5R01CA119905-03
|
$223,497
|
$111,749
|
Swaminathan, Sankar
|
UNIVERSITY OF FLORIDA
|
|
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
|
5R01CA079218-09
|
$328,425
|
$328,425
|
Gill, Parkash
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$70,351
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
Z01 BC 010871
|
$383,517
|
$76,704
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-33S1
|
$74,165
|
$336,641
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S1
|
$80,987
|
$49,046
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$43,908
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding the mechanism of KSHV latent DNA replication
|
5K99CA126182-02
|
$126,325
|
$126,325
|
Verma, Subhash
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tumor therapy with antiangiogenic beta-2-glycoprotein 1
|
5R01CA098527-05
|
$225,502
|
$45,100
|
SCHROIT, ALAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor and Metastasis Therapy
|
Z01 BC 011024
|
$402,995
|
$100,749
|
Khanna, Chand
|
CCR (NCI)
|
|
Training in Tumor Virology
|
5T32CA115299-03
|
$229,654
|
$45,931
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-07
|
$234,840
|
$234,840
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-12
|
$203,525
|
$10,176
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Tissue Array Research Program
|
Z01 BC 010923
|
$561,297
|
$28,065
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic Targets in Alveolar Rhabdomyosarcoma
|
1R01CA133229-01
|
$307,100
|
$307,100
|
KELLER, CHARLES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
The Role of XBP1 During Hypoxia and Tumor Growth
|
5R01CA112108-04
|
$223,293
|
$55,823
|
KOONG, ALBERT
|
STANFORD UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
$38,433
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Molecular and Cellular Basis of Cancer Immunoediting
|
5R01CA107527-05
|
$406,115
|
$406,115
|
SCHREIBER, ROBERT
|
WASHINGTON UNIVERSITY
|
|
The Molecular Analysis of Tumor Viruses
|
5T32CA009043-34
|
$624,449
|
$124,890
|
BISHOP, J
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
The Molecular Actions of Imatinib Mesylate in GISTs
|
5R01CA106588-05
|
$369,590
|
$369,590
|
GODWIN, ANDREW
|
FOX CHASE CANCER CENTER
|
|
The MiT Transcription Factor in Pediatric Malignancies
|
5R01CA102309-05
|
$299,147
|
$29,915
|
FISHER, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
|
The East Coast AIDS and Cancer Specimen Resource
|
2U01CA066535-14
|
$1,015,469
|
$253,867
|
SILVER, SYLVIA
|
GEORGE WASHINGTON UNIVERSITY
|
|
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma
|
5R01CA106281-04
|
$257,678
|
$257,678
|
RATAJCZAK, MARIUSZ
|
UNIVERSITY OF LOUISVILLE
|
|
Super-activity of gene regulators in fibrosarcoma
|
5F32CA119471-03
|
$50,428
|
$50,428
|
Kroch, Abigail
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Studying the role of KSHV-encoded microRNAs
|
1R01CA119917-01A2
|
$413,034
|
$413,034
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study of tumor pathogenesis and development of therapies for AIDS-malignancies
|
Z01 BC 010885
|
$497,035
|
$298,221
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of anti-angiogenesis enhanced radiotherapy
|
5R01CA107160-05
|
$228,182
|
$75,300
|
Griffin, Robert
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS
|
5R01CA069571-13
|
$310,162
|
$102,353
|
KINGSTON, DAVID
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-09
|
$348,813
|
$174,407
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of Childhood Solid Tumors
|
5P01CA023099-30
|
$2,219,539
|
$998,792
|
HOUGHTON, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Structure and Molecular Composition of KSHV an RRV
|
3R01CA088768-09S1
|
$51,474
|
$527,615
|
KEDES, DEAN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Stanford University Cancer Center
|
3P30CA124435-02S1
|
$80,833
|
$16,538
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Spontaneous Lytic Replication of KSHV
|
5R01CA111204-04
|
$233,708
|
$233,708
|
Vieira, Jeffrey
|
UNIVERSITY OF WASHINGTON
|
|
Solid Tumors
|
Z01 SC 006891
|
$542,949
|
$271,475
|
Helman, Lee
|
CCR (NCI)
|
|
Soft Tissue Sarcoma Program Project
|
5P01CA047179-17
|
$1,729,965
|
$1,729,965
|
SINGER, SAMUEL
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Sleeping Beauty for cancer gene discovery
|
7K01CA122183-03
|
$166,185
|
$109,682
|
Collier, Lara
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Shutoff of cellular gene expression by Kaposi's sarcoma-associated herpesvirus
|
5K01CA117982-03
|
$148,770
|
$148,770
|
GLAUNSINGER, BRITT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Secreted Frizzled-Related Proteins and Wnt Signaling
|
Z01 BC 010251
|
$590,160
|
$59,016
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Second cancers following retinoblastoma
|
Z01 CP010131-04140
|
$377,083
|
$113,125
|
Ron, Elaine
|
DCEG (NCI)
|
|
Role of p53 Missense Mutations on Tumorigenesis in Vivo
|
5R01CA082577-09
|
$256,010
|
$84,483
|
Lozano, Guillermina
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig
|
5R01CA085177-09
|
$236,554
|
$236,554
|
Chaudhary, Preet
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
1F31CA132560-01A1
|
$27,772
|
$27,772
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
Role of KSHV K1 in viral pathogenesis
|
5R01CA096500-07
|
$279,757
|
$279,757
|
DAMANIA, BLOSSOM
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Role of Cyclooxygenase-2 and PGE2 in KSHV pathogenesis
|
1R21CA128560-01A2
|
$190,575
|
$142,931
|
Sharma-Walia, Neelam
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Role of Chemokine Receptor ORF74 in Angioproliferation
|
5R01CA109259-05
|
$329,470
|
$329,470
|
LIRA, SERGIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
Total relevant funding to Sarcoma, Soft (Sarcoma Subset) for this search: $50,451,328
|